mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
mRNA |
Erlotinib |
FIMM |
pan-cancer |
AAC |
0.67 |
2e-05 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.23 |
4e-05 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
5e-05 |